Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System
09. März 2023 08:30 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative technology that...
Sight Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023
23. Februar 2023 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences to Present at the Upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference
22. Februar 2023 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences Announces 1,000th TearCare® Customer Installation
26. Januar 2023 08:30 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”) an eyecare technology company focused on creating innovative solutions...
Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Results
09. Januar 2023 16:20 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on creating innovative solutions...
Improvements in Signs and Symptoms of Dry Eye Disease From a Single TearCare® Treatment Sustained Through 12 Months
08. Dezember 2022 08:30 ET
|
Sight Sciences, Inc.
DATA PRESENTED AT THE 2022 AMERICAN ACADEMY OF OPTOMETRY MEETINGMEIBOMIAN GLAND FUNCTION IMPROVES BY 63% AND DRY EYE SYMPTOMS REDUCED BY 44% THROUGH 12 MONTHS MENLO PARK, Calif., Dec. 08, 2022 ...
Sight Sciences to Present at the Upcoming Piper Sandler 34th Annual Healthcare Conference
22. November 2022 08:30 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences Reports Third Quarter 2022 Financial Results
10. November 2022 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences Announces Publication of Clinical Data Demonstrating Standalone Effectiveness of the OMNI® Surgical System in Pseudophakic Glaucoma Patients with Uncontrolled Pressure Following a Previous Combination Cataract Stent Procedure
03. November 2022 08:30 ET
|
Sight Sciences, Inc.
Worldwide, more than one million trabecular microbypass stents have been implanted in combination with cataract surgery.Despite glaucoma medications and prior microbypass stenting, target IOP may no...
Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022
20. Oktober 2022 17:20 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...